Clinical Trial Update: GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis [Phase 3]

View source ↗

Summary

The Phase 3 vehicle-controlled study of GSK2894512 for adult plaque psoriasis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• GSK2894512

Snippet

Sponsor: GlaxoSmithKline | Conditions: Psoriasis | Phase 3 | Status: WITHDRAWN